T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$3.3B |
| 2 |
Eli Lilly
LLY
|
+$2.75B |
| 3 |
AstraZeneca
AZN
|
+$1.98B |
| 4 |
Coupang
CPNG
|
+$1.54B |
| 5 |
Fortinet
FTNT
|
+$1.48B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$2.34B |
| 2 |
Morgan Stanley
MS
|
+$2.26B |
| 3 |
Airbnb
ABNB
|
+$2.04B |
| 4 |
Qualcomm
QCOM
|
+$1.95B |
| 5 |
NVIDIA
NVDA
|
+$1.81B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.35% |
| 2 | Healthcare | 16.19% |
| 3 | Consumer Discretionary | 15.55% |
| 4 | Financials | 12.84% |
| 5 | Communication Services | 12.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Great Southern Bancorp
GSBC
$888M
| $350K | ﹤0.01% |
+6,180
| New | +$330K |
|
|
MAGN
2502
Magnera Corp
MAGN
$433M
| $350K | ﹤0.01% |
1,571
+279
| +22% | +$62.1K |
|
2503
Ribbon Communications
RBBN
$377M
| $349K | ﹤0.01% |
42,518
+109
| +0.3% | +$902 |
|
|
FOCS
2504
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $349K | ﹤0.01% |
+8,394
| New | +$406K |
|
2505
Inseego
INSG
$77.7M
| $346K | ﹤0.01% |
3,455
-1,646
| -32% | -$240K |
|
2506
Manitowoc
MTW
$753M
| $346K | ﹤0.01% |
16,803
-31,296
| -65% | -$517K |
|
|
MITT
2507
TPG Mortgage Investment Trust
MITT
$214M
| $345K | ﹤0.01% |
28,567
+16,667
| +140% | +$189K |
|
2508
Pulse Biosciences
PLSE
$3.2B
| $343K | ﹤0.01% |
14,480
-3,507
| -19% | -$105K |
|
2509
Alaunos Therapeutics
TCRT
$4.86M
| $341K | ﹤0.01% |
631
-89
| -12% | -$55.4K |
|
|
CNBKA
2510
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $339K | ﹤0.01% |
3,631
-25
| -0.7% | -$2.17K |
|
2511
Funko
FNKO
$335M
| $338K | ﹤0.01% |
+17,167
| New | +$239K |
|
2512
Dillards
DDS
$9.59B
| $336K | ﹤0.01% |
3,482
-7,507
| -68% | -$610K |
|
2513
Quantum Corp
QMCO
$973M
| $336K | ﹤0.01% |
+2,014
| New | +$321K |
|
|
VBIV
2514
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $336K | ﹤0.01% |
3,603
+24
| +0.7% | +$2.43K |
|
|
ASXC
2515
DELISTED
Asensus Surgical, Inc.
ASXC
| $335K | ﹤0.01% |
+103,000
| New | +$373K |
|
2516
Veru
VERU
$46M
| $333K | ﹤0.01% |
3,086
-331
| -10% | -$41.7K |
|
2517
ALX Oncology
ALXO
$268M
| $330K | ﹤0.01% |
+4,474
| New | +$352K |
|
2518
KLX Energy Services
KLXE
$36M
| $329K | ﹤0.01% |
+20,500
| New | +$255K |
|
2519
Rhythm Pharmaceuticals
RYTM
$7.99B
| $329K | ﹤0.01% |
15,465
+195
| +1% | +$5.66K |
|
2520
nLIGHT
LASR
$2.9B
| $327K | ﹤0.01% |
10,097
+20
| +0.2% | +$708 |
|
|
WHWK
2521
Whitehawk Therapeutics
WHWK
$267M
| $327K | ﹤0.01% |
+16,913
| New | +$389K |
|
|
SPNE
2522
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $327K | ﹤0.01% |
18,776
+61
| +0.3% | +$1.09K |
|
2523
Digimarc Corp
DMRC
$158M
| $326K | ﹤0.01% |
10,977
-2,420
| -18% | -$96K |
|
|
ACR
2524
ACRES Commercial Realty
ACR
$101M
| $325K | ﹤0.01% |
+22,265
| New | +$296K |
|
|
CARM
2525
DELISTED
Carisma Therapeutics
CARM
| $325K | ﹤0.01% |
+6,255
| New | +$295K |
|
Similar funds
T. Rowe Price Associates's Q1 2021 Portfolio in Review
As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
- T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
- T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
- T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
- T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
- T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.